Scientists are using 'elite' antibodies from COVID-19 survivors to develop potent therapies
In the few weeks since New York City came to a socially distanced halt, more than 250 COVID-19 survivors have visited Rockefeller's otherwise quiet campus to contribute their blood to science. Here, a group of immunologists, ...